CD8A and neoplasm: Nevertheless, we observed a decrease in CD8+ cells in the CAC mice treated with 5-FU, and a slight increase in these for therapies with AS1517499 and Trimethylglycine; however, these results do not discard the possible effect of CD8+ cells in the tumor site, and their possible participation in tumor rejection observed in the mice treated with AS+5-FU.